NEW YORK, April 23, 2018 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of investors who purchased Colony NorthStar, Inc. ("Colony NorthStar") (NYSE:CLNS) securities between February 28, 2017 and March 1, 2018.
Click here to learn about the case: http://www.wongesq.com/pslra-c/colony-northstar-inc?wire=3. There is no cost or obligation to you.
According to the complaint, throughout the Class Period, the Company issued materially false and misleading statements and/or failed to disclose that: (1) Colony NorthStar’s Healthcare and Investment Management segments were performing worse than reported; (2) as a result, the Company’s public statements were materially false and misleading at all relevant times.
If you suffered a loss in Colony NorthStar you have until June 5, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-c/colony-northstar-inc?wire=3.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]


Valero Energy Expands Venezuelan Crude Imports as U.S. Sanctions Ease
Vietnam Approves SpaceX Starlink Satellite Internet Service Amid U.S. Trade Talks
Macquarie-Led Consortium to Acquire Qube Holdings in A$11.7 Billion Deal
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth
Treasury Wine Estates Profit Falls 46% as China and U.S. Inventory Reset Weighs on Earnings
How Marco Pharma International Preserves German Homeopathic Traditions in America
Mitsui Kinzoku Stock Surges to Record High After Profit Forecast Upgrade and Dividend Increase
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development
BlueScope Steel Forecasts Stronger Second-Half Earnings, Shares Rise Above Rejected Buyout Offer
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy
Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle
Senators Urge CFIUS Review of UAE Investment in Trump-Linked Crypto Firm World Liberty Financial
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Anthropic’s Claude AI Reportedly Used in U.S. Operation to Capture Nicolas Maduro 



